392 related articles for article (PubMed ID: 15993779)
1. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
2. The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft.
Suemitsu R; Yoshino I; Shoji F; Yamaguchi M; Tomita Y; Maehara Y
J Surg Res; 2004 Nov; 122(1):8-13. PubMed ID: 15522308
[TBL] [Abstract][Full Text] [Related]
3. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development.
Hollmén M; Tikkanen JM; Nykänen AI; Koskinen PK; Lemström KB
J Heart Lung Transplant; 2008 Aug; 27(8):856-64. PubMed ID: 18656798
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the obliteration process by ventilation in a mouse orthotopic tracheal transplantation model.
Chen C; Zhang YZ; Zheng H; Xu BB; Gao W
Transplantation; 2009 Jun; 87(12):1762-8. PubMed ID: 19543051
[TBL] [Abstract][Full Text] [Related]
6. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
9. The role of cyclosporine A and interleukin-2 in obliterative airway disease in a rat tracheal transplant model.
Gu Y; Takao M; Kai M; Lu L; Shimamoto A; Onoda K; Shimono T; Tanaka K; Shimpo H; Shiraishi T; Yada I
Ann Thorac Cardiovasc Surg; 2000 Aug; 6(4):224-31. PubMed ID: 11042477
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model.
Nusair S; Or R; Junadi S; Amir G; Breuer R
Chest; 2005 Dec; 128(6):4024-9. PubMed ID: 16354876
[TBL] [Abstract][Full Text] [Related]
11. Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
Deuse T; Schrepfer S; Reichenspurner H; Hoyt G; Fischbein MP; Robbins RC; Pelletier MP
Transpl Immunol; 2007 Jun; 17(4):255-61. PubMed ID: 17493528
[TBL] [Abstract][Full Text] [Related]
12. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
[TBL] [Abstract][Full Text] [Related]
13. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation.
Oyaizu T; Okada Y; Shoji W; Matsumura Y; Shimada K; Sado T; Sato M; Kondo T
Transplantation; 2003 Oct; 76(8):1214-20. PubMed ID: 14578756
[TBL] [Abstract][Full Text] [Related]
14. Inducible costimulator blockade prolongs airway luminal patency in a mouse model of obliterative bronchiolitis.
KleinJan A; Willart MA; Kuipers H; Coyle AJ; Hoogsteden HC; Lambrecht BN
Transplantation; 2008 Nov; 86(10):1436-44. PubMed ID: 19034015
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
[TBL] [Abstract][Full Text] [Related]
16. Mixed allogeneic chimerism prevents obstructive airway disease in a rat heterotopic tracheal transplant model.
Gammie JS; Li S; Kawaharada N; Colson YL; Yousem S; Ildstad ST; Pham SM
J Heart Lung Transplant; 1998 Aug; 17(8):801-8. PubMed ID: 9730430
[TBL] [Abstract][Full Text] [Related]
17. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
[TBL] [Abstract][Full Text] [Related]
18. Anti-allergic agent tranilast decreases development of obliterative airway disease in rat model of heterotopic tracheal transplantation.
Okada Y; Matsumura Y; Shimada K; Sado T; Oyaizu T; Sugawara T; Matsuda Y; Hoshikawa Y; Takahashi H; Sato M; Kondo T
J Heart Lung Transplant; 2004 Dec; 23(12):1392-5. PubMed ID: 15607669
[TBL] [Abstract][Full Text] [Related]
19. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
[TBL] [Abstract][Full Text] [Related]
20. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
Zhou H; Latham CW; Zander DS; Margolin SB; Visner GA
J Heart Lung Transplant; 2005 Oct; 24(10):1577-85. PubMed ID: 16210133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
